Jubilant Life Sciences surges as its arm sells hospital business to Narayana Health

04 Mar 2014 Evaluate

Jubilant Life Sciences is currently trading at Rs. 144.60, up by 7.60 points or 5.55% from its previous closing of Rs. 137.00 on the BSE.

The scrip opened at Rs. 143.00 and has touched a high and low of Rs. 147.50 and Rs. 141.55 respectively. So far 78,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 190.00 on 12-Mar-2013 and a 52 week low of Rs. 65.10 on 28-Aug-2013.

Last one week high and low of the scrip stood at Rs. 147.50 and Rs. 115.80 respectively. The current market cap of the company is Rs. 2,293.00 crore.

The promoters holding in the company stood at 53.95% while Institutions and Non-Institutions held 26.50% and 19.55% respectively.

Jubilant Life Sciences’ wholly owned subsidiary - Jubilant First Trust Healthcare (JFTH), has sold its hospital business to Narayana Health. Anand Rathi Advisors were the Investment Bankers for the deal.

The business has been transferred on a going concern basis as a slump sale which will enable Jubilant Life Sciences to focus on its core businesses in Pharmaceuticals and Life Sciences. JFTH operates two hospitals in West Bengal, Kalpataru in Barasat and Rabindranath Thakur in Berhampore.

Jubilant Life Sciences is a global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients. 

Jubilant Pharmova Share Price

1065.05 2.00 (0.19%)
23-Dec-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1814.50
Dr. Reddys Lab 1341.60
Cipla 1476.45
Lupin 2168.25
Zydus Lifesciences 972.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.